PAPER de Jager CA
SEARCH RESULTS
331254 RESULTS
PAPER Quiroga C, Chaparro RE, Karlnoski R, Erasso D, Gordon M, Morgan D, Bosco G, Rubini A, Parmagnani A, Paoli A, Mangar D, Camporesi EM
Effects of repetitive exposure to anesthetics and analgesics in the Tg2576 mouse Alzheimer's model.
Neurotox Res. 2014 Nov;26(4):414-21. Epub 2014 Jun 14 PubMed: 24927827PAPER Zis P, Rizos A, Martinez-Martin P, Pal S, Silverdale M, Sharma JC, Sauerbier A, Chaudhuri KR
Non-motor symptoms profile and burden in drug naïve versus long-term Parkinson's disease patients.
J Parkinsons Dis. 2014 Jan 1;4(3):541-7. PubMed: 24927755PAPER Villarreal AE, Barron R, Rao KS, Britton GB
The effects of impaired cerebral circulation on Alzheimer's disease pathology: evidence from animal studies.
J Alzheimers Dis. 2014;42(3):707-22. PubMed: 24927711PAPER Trujillo-Estrada L, Dávila JC, Sánchez-Mejias E, Sánchez-Varo R, Gomez-Arboledas A, Vizuete M, Vitorica J, Gutiérrez A
Early neuronal loss and axonal/presynaptic damage is associated with accelerated amyloid-β accumulation in AβPP/PS1 Alzheimer's disease mice subiculum.
J Alzheimers Dis. 2014;42(2):521-41. PubMed: 24927710PAPER Wang C, Yu JT, Wang HF, Tan CC, Meng XF, Tan L
Non-pharmacological interventions for patients with mild cognitive impairment: a meta-analysis of randomized controlled trials of cognition-based and exercise interventions.
J Alzheimers Dis. 2014;42(2):663-78. PubMed: 24927709PAPER Mato Abad V, Quirós A, García-Álvarez R, Loureiro JP, Alvarez-Linera J, Frank A, Hernández-Tamames JA
The partial volume effect in the quantification of 1H magnetic resonance spectroscopy in Alzheimer's disease and aging.
J Alzheimers Dis. 2014;42(3):801-11. PubMed: 24927708PAPER Martin SB, Dowling AL, Lianekhammy J, Lott IT, Doran E, Murphy MP, Beckett TL, Schmitt FA, Head E
Synaptophysin and synaptojanin-1 in Down syndrome are differentially affected by Alzheimer's disease.
J Alzheimers Dis. 2014;42(3):767-75. PubMed: 24927707PAPER Farías GA, Guzmán-Martínez L, Delgado C, Maccioni RB
Nutraceuticals: a novel concept in prevention and treatment of Alzheimer's disease and related disorders.
J Alzheimers Dis. 2014;42(2):357-67. PubMed: 24927706PAPER Serrano GE, Sabbagh MN, Sue LI, Hidalgo JA, Schneider JA, Bedell BJ, Van Deerlin VM, Suh E, Akiyama H, Joshi AD, Pontecorvo MJ, Mintun MA, Beach TG
Positive florbetapir PET amyloid imaging in a subject with frequent cortical neuritic plaques and frontotemporal lobar degeneration with TDP43-positive inclusions.
J Alzheimers Dis. 2014;42(3):813-21. PubMed: 24927705PAPER Keage HA, Hunter S, Matthews FE, Ince PG, Hodges J, Hokkanen S, Highley JR, Dening T, Brayne C
TDP-43 in the Population: Prevalence and Associations with Dementia and Age.
J Alzheimers Dis. 2014 Jun 13; PubMed: 24927703PAPER Guo H, Song X, Schmidt MH, Vandorpe R, Yang Z, LeBlanc E, Zhang J, Beyea S, Zhang Y, Rockwood K
Evaluation of whole brain health in aging and Alzheimer's disease: a standard procedure for scoring an MRI-based brain atrophy and lesion index.
J Alzheimers Dis. 2014;42(2):691-703. PubMed: 24927702PAPER Peter J, Abdulkadir A, Kaller C, Kümmerer D, Hüll M, Vach W, Klöppel S
Subgroups of Alzheimer's disease: stability of empirical clusters over time.
J Alzheimers Dis. 2014;42(2):651-61. PubMed: 24927700PAPER Rodrigues R, Petersen RB, Perry G
Parallels between major depressive disorder and Alzheimer's disease: role of oxidative stress and genetic vulnerability.
Cell Mol Neurobiol. 2014 Oct;34(7):925-49. Epub 2014 Jun 14 PubMed: 24927694PAPER Ross CA, Akimov SS
Human-induced pluripotent stem cells: potential for neurodegenerative diseases.
Hum Mol Genet. 2014 Sep 15;23(R1):R17-26. Epub 2014 May 13 PubMed: 24824217Current Filters
No filters selected